oxybutynin has been researched along with bisoprolol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 6 (26.09) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cun, D; Fang, L; Song, W; Xi, H | 1 |
| Kuwajima, I; Matsuoka, H; Mitamura, H; Saruta, T; Shimada, K | 1 |
| Chen, Y; Cui, H; Cun, D; Fang, L; Liu, N; Quan, P; Song, W; Xiang, R | 1 |
| Akaike, M; Hara, T; Sata, M; Yagi, S | 1 |
| Fang, L; Li, S; Liu, C; Lv, S; Quan, P; Song, W; Zhao, Y | 1 |
| Doi, K; Hiruma, T; Inokuchi, R; Nakajima, S; Nakamura, K; Tokunaga, K | 1 |
| Aoki, J; Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Shinohara, M; Suzuki, T; Tanabe, K; Yuzawa, H | 1 |
| Daimon, M; Dohi, N; Kinugawa, K; Komuro, I; Momomura, SI; Okamoto, H; Saito, Y; Sakata, Y; Yamamoto, K; Yasumura, Y | 1 |
| Enomoto, S; Hamuro, M; Kawatou, M; Yamada, T; Yamamoto, K | 1 |
| Kihara, Y; Nakano, Y; Oda, N; Ono, K; Sairaku, A; Shiode, N; Suenari, K | 1 |
| Akhtar, FM; Ali, S; Fazli, AR; Manan, A; Manzoor, I; Raza, M; Shabbir, M; Sharif, A; Younas, N | 1 |
| Akita, Y; Ikeda, T; Yamashita, T | 1 |
| Daida, H; Kamiyama, T; Kanoh, T; Matsumoto, T; Takabe, T; Tamiya, E; Yamamoto, S | 1 |
| Endo, M; Enjoji, Y; Kanmatuse, K; Nishinaga, M; Shimura, Y; Yamazaki, D | 1 |
| Imori, Y; Izumi, Y; Mase, H; Matsuda, J; Sangen, H; Shimizu, W; Takano, H; Tokita, Y; Yamamoto, T | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T; Sano, T | 1 |
| Ejiri, K; Hayashi, M; Hikasa, Y; Ito, H; Iwano, T; Miyoshi, T; Morimatsu, H; Morita, H; Nakagawa, K; Nakamura, K; Nishii, N; Shimizu, K; Toda, H; Watanabe, A; Yoshida, M | 1 |
| Horiuchi, N; Kobayashi, T; Kobayashi, Y; Nakamura, S; Nakanishi, H; Naruhashi, K; Nozaki, A; Okugawa, H | 1 |
| Ejiri, K; Hikasa, Y; Ito, H; Iwano, T; Masuda, T; Miyoshi, T; Mori, H; Morimatsu, H; Naito, Y; Nakamura, K; Shimizu, K; Toda, H; Yoshida, M | 1 |
| Asano, A; Nakai, K; Tsuruta, D | 1 |
1 review(s) available for oxybutynin and bisoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for oxybutynin and bisoprolol
| Article | Year |
|---|---|
Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Asian People; Bisoprolol; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Essential Hypertension; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Safety; Severity of Illness Index; Transdermal Patch; Treatment Outcome | 2013 |
Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Transdermal Patch; Ventricular Premature Complexes | 2017 |
Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Asian People; Bisoprolol; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Transdermal Patch; Treatment Outcome | 2017 |
Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Atrial Fibrillation; Bisoprolol; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Transdermal Patch | 2019 |
Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Computed Tomography Angiography; Coronary Angiography; Female; Heart Rate; Humans; Male; Middle Aged; Pilot Projects; Transdermal Patch | 2020 |
Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery - Multicenter Randomized Controlled Study.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Biomarkers; Bisoprolol; Female; Heart Diseases; Humans; Incidence; Japan; Male; Prospective Studies; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Time Factors; Transdermal Patch; Treatment Outcome; Troponin T | 2020 |
Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
Topics: Aged; Atrial Fibrillation; Bisoprolol; Humans; Postoperative Complications; Risk Factors; Stroke; Transdermal Patch | 2021 |
15 other study(ies) available for oxybutynin and bisoprolol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The control of skin-permeating rate of bisoprolol by ion-pair strategy for long-acting transdermal patches.
Topics: Administration, Cutaneous; Animals; Bisoprolol; Delayed-Action Preparations; Organ Culture Techniques; Rabbits; Skin; Skin Absorption; Transdermal Patch | 2012 |
Dual-directional regulation of drug permeating amount by combining the technique of ion-pair complexation with chemical enhancers for the synchronous permeation of indapamide and bisoprolol in their compound patch through rabbit skin.
Topics: Animals; Azepines; Bisoprolol; Chemistry, Pharmaceutical; Down-Regulation; Drug Combinations; Drug Interactions; Drug Liberation; Excipients; Hexoses; In Vitro Techniques; Indapamide; Injections, Intravenous; Male; Permeability; Pyrrolidinones; Rabbits; Skin; Skin Absorption; Tartrates; Transdermal Patch; Up-Regulation | 2015 |
Transdermal patch of bisoprolol for the treatment of hypertension complicated with aortic dissection.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Bisoprolol; Humans; Hypertension; Male; Middle Aged; Transdermal Patch; Treatment Outcome | 2015 |
Probing the role of chemical enhancers in facilitating drug release from patches: Mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis.
Topics: Adhesives; Administration, Cutaneous; Animals; Antihypertensive Agents; Bisoprolol; Drug Delivery Systems; Drug Liberation; Excipients; Hexoses; Rabbits; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Transdermal Patch | 2016 |
Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Blood Pressure; Critical Care; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Retrospective Studies; Transdermal Patch; Urea | 2016 |
[Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atrial Fibrillation; Bisoprolol; Cardiac Surgical Procedures; Female; Humans; Male; Middle Aged; Transdermal Patch; Treatment Outcome | 2017 |
Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Tablets; Transdermal Patch | 2018 |
EFFECT OF HYDROPHILIC AND HYDROPHOBIC POLYMER ON IN VITRO DISSOLUTION AND PERMEATION OF BISOPROLOL FUMARATE THROUGH TRANSDERMAL PATCH.
Topics: Animals; Bisoprolol; Hydrophobic and Hydrophilic Interactions; Permeability; Polymers; Rabbits; Solubility; Transdermal Patch | 2017 |
Supraventricular tachyarrhythmias that responded dramatically to bisoprolol transdermal patches in two patients undergoing hemodialysis.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Electrocardiography; Female; Humans; Male; Renal Dialysis; Tachycardia, Supraventricular; Transdermal Patch; Treatment Outcome | 2019 |
Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Perioperative Care; Registries; Retrospective Studies; Time Factors; Transdermal Patch; Treatment Outcome | 2019 |
Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Pressure; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Outcome Assessment, Health Care; Transdermal Patch | 2020 |
An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
Topics: Acute Coronary Syndrome; Acute Disease; Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Bisoprolol; Disease Progression; Drug Administration Schedule; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Time-to-Treatment; Transdermal Patch; Treatment Outcome | 2021 |
Lichenoid drug eruption associated with bisoprolol transdermal patches.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Delayed-Action Preparations; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Transdermal Patch | 2022 |